Positive outcome no more likely in industry-funded trials

July 5, 2012
Positive outcome no more likely in industry-funded trials
Industry-sponsored clinical trials of rheumatoid arthritis drugs are no more likely to report positive outcomes than trials funded by other means, and in many cases use better methodology, according to research published in the July issue of Arthritis & Rheumatism.

(HealthDay) -- Industry-sponsored clinical trials of rheumatoid arthritis drugs are no more likely to report positive outcomes than trials funded by other means, and in many cases use better methodology, according to research published in the July issue of Arthritis & Rheumatism.

Nasim A. Khan, M.D., from the University of Arkansas for Medical Sciences in Little Rock, and colleagues reviewed 103 randomized controlled trials (RCTs) for rheumatoid drugs to examine whether industry funding was associated with outcomes.

The researchers found that 56.3 percent of RCTs were funded by industry, 18.4 percent were funded through nonprofit sources, 5.8 percent had mixed funding, and the funding source was not specified in the remaining 19.4 percent. In the 86 trials examined for outcomes there was no correlation between industry funding and positive outcomes (75.5 percent for industry versus 68.8 percent for non-industry, 40 percent for mixed, and 81.2 percent for unspecified). Industry-funded studies were more likely not to be published (P = 0.093) but were more likely to be double-blinded, adequately describe participant flow, and perform an intent-to-treat analysis.

"Industry funding was not associated with a higher likelihood of positive outcomes of published RCTs of drug therapy for , and industry-funded RCTs performed significantly better than non-industry-funded RCTs in terms of reporting the use of some key methodologic quality measures," Khan and colleagues conclude.

Explore further: Study reveals that financial conflicts of interest are associated with positive study outcomes

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Recommended for you

Cross-species links identified for osteoarthritis

May 17, 2017

New research from the University of Liverpool, published today in the journal npj Systems Biology and Applications, has identified 'cell messages' that could help identify the early stages of osteoarthritis (OA).

Anti-hypertension DASH diet may reduce the risk of gout

May 9, 2017

The results of a study led by Massachusetts General Hospital (MGH) investigators suggest that following a diet known to reduce the risk of hypertension and cardiovascular disease may also reduce the risk of gout. The team's ...

High-fat, high-carb diet a cause of osteoarthritis

April 18, 2017

Saturated fat is a prime suspect in the onset of osteoarthritis after QUT scientists found it changed the composition of cartilage, particularly in the weight-bearing joints of the hip and knee.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

Gys
not rated yet Jul 06, 2012
I just downloaded the full text of this article and there is no statement about the conflict of interest for the authors. Which makes me laugh.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.